KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Non-Current Deferred Tax Liability (2020 - 2025)

AbCellera Biologics (ABCL) has disclosed Non-Current Deferred Tax Liability for 6 consecutive years, with $9.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Deferred Tax Liability fell 23.76% year-over-year to $9.7 million, compared with a TTM value of $9.7 million through Sep 2025, down 23.76%, and an annual FY2024 reading of $10.1 million, down 67.16% over the prior year.
  • Non-Current Deferred Tax Liability was $9.7 million for Q3 2025 at AbCellera Biologics, down from $10.1 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $37.4 million in Q4 2021 and bottomed at $9.7 million in Q3 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $26.3 million, with a median of $30.6 million recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability surged 42.85% in 2021, then tumbled 67.16% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $37.4 million in 2021, then fell by 11.22% to $33.2 million in 2022, then dropped by 7.73% to $30.6 million in 2023, then crashed by 67.16% to $10.1 million in 2024, then decreased by 3.06% to $9.7 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for ABCL at $9.7 million in Q3 2025, $10.1 million in Q2 2025, and $10.1 million in Q1 2025.